Daniel A. Rodrigues
123 St Stephen's Green, 2
Dublin, L, Ireland
Dublin, L, Ireland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Fulfilling multiple roles in PROTAC design: The emerging potential of oligonucleotides.
Journal: European journal of medicinal chemistry
Published: November 17, 2025
Design, Synthesis, and Biological Evaluation of Novel Triazine-Based Dual Histone Deacetylase/phosphatidylinositol 3-kinase Inhibitors for Breast Cancer Therapy.
Journal: ChemMedChem
Published: November 17, 2025
Discovery of N‑Acylhydrazone Derivatives as ROCK Inhibitors: A Journey from Virtual Screening and Structure-Based De Novo Design to the Identification of ROCK2 Selective Inhibitors and Beyond.
Journal: ACS bio & med chem Au
Published: November 11, 2025
Design, synthesis and pharmacological evaluation of multitarget GPR40 agonists/HDAC6 inhibitors for Alzheimer's disease.
Journal: European journal of medicinal chemistry
Published: May 11, 2025
Drug Discovery for Histone Deacetylase Inhibition: Past, Present and Future of Zinc-Binding Groups.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: March 16, 2025
Selective inhibition of HDAC6 by N-acylhydrazone derivative reduces the proliferation and induces senescence in carcinoma hepatocellular cells.
Journal: Toxicology in vitro : an international journal published in association with BIBRA
Published: May 03, 2024
Click-Capable Phenanthriplatin Derivatives as Tools to Study Pt(II)-Induced Nucleolar Stress.
Journal: ACS chemical biology
Published: March 14, 2024
First-in-class metallo-PROTAC as an effective degrader of select Pt-binding proteins.
Journal: Chemical communications (Cambridge, England)
Published: October 04, 2023
Identification of a mechanism-based binding mode for a histone deacetylase 6 inhibitor.
Journal: Nature communications
Published: September 26, 2023
The path to venetoclax resistance is paved with mutations, metabolism, and more.
Journal: Science translational medicine
Published: December 08, 2022
Histone Deacetylase 6 Inhibition Exploits Selective Metabolic Vulnerabilities in LKB1 Mutant, KRAS Driven NSCLC.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: August 16, 2022
Last Updated: 09/26/2026